World Bank report urges African governments, development aid donors to increase HIV prevention efforts

"With much of the global economy facing slowing growth and uncertain prospects, especially in developed countries, a new World Bank report" -- titled "The Fiscal Dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda" -- "urges African governments and their development aid donors to do significantly more to prevent new HIV infections" and "warns that current spending on HIV/AIDS relates to past infections and is a potentially misleading indicator of the long-term public cost of the fight against HIV/AIDS," a World Bank press release states. According to the press release, "The report argues that governments need to better assess the financial sustainability and allocative efficiency of their national HIV/AIDS responses over time so as to sustainably manage the long-term burden of HIV/AIDS" (3/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug